HB1644, titled the Copay Fairness for Veterans Act, would amend title 38 of the U.S. Code to eliminate Department of Veterans Affairs copayments for preventive health services and for medicines that are part of those services. The bill defines preventive health services to include evidence-based items and services rated A or B by the U.S. Preventive Services Task Force, recommended immunizations, and specified women’s preventive care, screenings, and contraceptives, including FDA-approved, cleared, or granted contraceptives and related care.
The measure would also revise VA eligibility and cost-sharing provisions so that veterans would not be liable for amounts associated with preventive health services under the affected sections of title 38. In practical terms, the bill would expand no-cost access to preventive care within the VA health system and remove copays for a broader set of preventive medications, screenings, vaccines, and reproductive health services.
Impact
If enacted, the bill would amend sections 1701, 1710, and 1722A of title 38, United States Code, changing VA law to bar copayments for preventive health services and related medications. It would directly affect veterans receiving care through the VA by reducing out-of-pocket costs for covered preventive services, while also requiring the VA to adjust its billing and cost-sharing rules to conform to the new statutory definitions and exemptions.
Sentiment
The available legislative history suggests generally favorable treatment of the bill, as it was forwarded by subcommittee to the full committee by voice vote. No recorded roll-call vote or committee transcript is available in the provided materials, but the voice-vote action indicates the measure likely faced little formal opposition at that stage. The bill’s sponsors also signal support for expanding veterans’ access to preventive care without cost-sharing.
Contention
The text itself shows the main policy choices that could generate debate: the scope of what counts as preventive health services, the inclusion of contraceptives and related reproductive health care, and the fiscal effect of eliminating copays for a wider set of VA services. Those issues could draw differing views from lawmakers concerned about veterans’ access and public health versus those focused on VA costs, benefit expansion, or the breadth of coverage for women’s health and contraception. No specific objections are documented in the provided committee materials.
To amend title 38, United States Code, to direct the Secretary of Veterans Affairs to furnish an opioid antagonist to a veteran without requiring a prescription or copayment.